治疗复发或耐药多发性骨髓瘤患者的Selinexor
Anum Babar1, Maham Babar2, Hina Zubair3
1Khyber Girls Medical College, Peshawar, Pakistan.
概括
塞林克索在治疗复发性/耐药性多发性骨髓瘤方面表现有前途,通过向出口1. 临床试验表明,当与其他疗法相结合时,它在改善无进展生存率和整体反应率方面具有有效性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性骨髓瘤细胞表现出对常规治疗的耐药性,原因是出口in 1水平升高.
- 塞利尼克索是一种新型治疗剂,旨在抑制多发性骨髓瘤细胞中的出口素1活性.
研究的目的:
- 评估selinexor在复发/耐药多发性骨髓瘤患者的疗效和安全性.
- 评估Selinexor在治疗多发性骨髓瘤的联合治疗方案中的治疗潜力.
主要方法:
- 使用PubMed,谷歌学者和clinicaltrials.gov.gov进行了系统的文献审查.
- 分析了包括STORM,BOSTON和STOMP在内的临床试验数据,以确定疗效和安全结果.
主要成果:
- 风暴试验表明无进展生存期 (PFS) 为4.7个月 (第一部分) 和3.7个月 (第二部分).
- 波斯顿试验的塞利尼克索尔,博尔特佐米布和甲 (SVd) 臂显示PFS的中位数为13.93个月,而博尔特佐米布和甲 (Vd) 的PFS为9.46个月.
- 包括selinexor在内的组合疗法在不同患者亚组中显示了总体响应率,从54.3%到91.7%.
结论:
- 塞利尼克索尔在改善复发性/耐药性多发性骨髓瘤患者的治疗结果方面显示出显著的潜力.
- 对治疗协同作用和克服耐药性的进一步研究对于优化基于selinexor的治疗至关重要.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K